In the field of cancer, intrabodies have been used to modulate the expression of proteins upregulated in tumors, such as erbB-2, interleukin-2 receptor, cyclin E (cell cycle protein), and EGFR [100-109]. The gene discussed is ERBB2; the disease is cancer.